Antiarrhythmic Drug Identified as Potential Treatment for Pulmonary Arterial Hypertension (IMAGE)

Elsevier

Antiarrhythmic Drug Identified as Potential Treatment for Pulmonary Arterial Hypertension

Caption

Image demonstrates pulmonary arteries (PAs) and lung tissue from control, pulmonary arterial hypertension (PAH), and PAH and dofetilide treated rats. W indicates wall and L indicates lumen. Scale bars = 50 μm. Treatment with dofetilide inhibits pulmonary vascular remodeling associated with PAH, including wall thickening and lumen occlusion. .

Credit

Shults, N.V., Rybka, V., Suzuki, Y.J., and Brelidze, T.I.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.